Form 4 for RPRX Royalty Pharma plc

Accepted 2025-07-31 00:00:00 ET · period of report 2025-07-31 · accession 0001802768-25-000088 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-07-31	2025-07-31	RPRX	Ho Carole	Dir	A - Grant	$0.00	+8,558	2,752	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Ordinary Shares	2025-07-31	A	A	5,806	$0.00	8,558	D	—	—	(F2) Reflects a pro-rated annual equity award of restricted stock units under the Plan that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
2	Common	Class A Ordinary Shares	2025-07-31	A	A	2,752	$0.00	2,752	D	—	—	(F1) Reflects an initial equity award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.